Market News AIOpen the app

VRCA stock news · Verrica Pharmaceuticals Inc.

Stories about Verrica Pharmaceuticals Inc. (VRCA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for VRCA

Follow Verrica Pharmaceuticals Inc. (VRCA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VRCA
Free on the App Store and Google Play, or on the web.
  1. Nov 12, 2026, 4:30 PM ET · Market

    Verrica Pharmaceuticals shared its third quarter results, showing record sales of $5.7 million from YCANTH.

    Good or bad for VRCA?
  2. Nov 12, 2026, 4:29 PM ET · Market

    Verrica Pharmaceuticals made $5.7 million from YCANTH sales last quarter, up 11.9% from the last quarter.

    Good for VRCA

    Verrica reported $5.7 million in YCANTH sales, up 11.9% from the prior quarter and 57.9% from a year earlier. Sales growth and funding for upcoming trials make the update favorable.

  3. Oct 14, 2026, 5:40 AM ET · Results

    Verrica Pharmaceuticals shares the details from its earnings call for the second quarter of 2026.

    Good for VRCA

    YCANTH sales rose, and investor funding is expected to cover operations into 2028. Growing sales and added cash support Verrica, though key study results are still ahead.